Prescribing anti-amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions

被引：4

作者：

Greenberg, Barry D. ^{[1
]}

Lemere, Cynthia A. ^{[2
]}

Barnes, Lisa L. ^{[3
]}

Hayden, Kathleen M. ^{[4
]}

Kukull, Walter A. ^{[5
]}

Oh, Esther S. ^{[6
,7
,8
]}

Snyder, Peter J. ^{[9
]}

Supiano, Mark ^{[10
]}

Dilworth-Anderson, Peggye ^{[11
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Neurol, Reed Hall 1West,Room 101A,1620 McElderry St, Baltimore, MD 21205 USA

[2] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA

[3] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL USA

[4] Wake Forest Univ, Sch Med, Winston Salem, NC USA

[5] Univ Washington, Dept Epidemiol, Seattle, WA USA

[6] Johns Hopkins Univ, Dept Med, Sch Med, Baltimore, MD USA

[7] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD USA

[8] Johns Hopkins Univ, Dept Pathol, Sch Med, Baltimore, MD USA

[9] Brown Univ, Univ Rhode Isl Dept Neurol, Dept Biomed & Pharmaceut Sci, Coll Pharm,Alpert Med Sch, Providence, RI USA

[10] Univ Utah, Spencer Eccles Fox Sch Med, Div Geriatr, Sch Aging, Salt Lake City, UT USA

[11] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA

来源：

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS | 2023年 / 9卷 / 04期

关键词：

D O I：

10.1002/trc2.12426

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页数：4

共 50 条

[1] Open peer commentary on "Prescribing anti-amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions"
Gandy, Sam
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2023, 9 (04)
[2] Commentary on Greenberg et al., "Prescribing anti-amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions"
Hill, Carl V.
Pike, Joanne
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2024, 10 (01)
[3] Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update
Yadollahikhales, Golnaz
Rojas, Julio C.
NEUROTHERAPEUTICS, 2023, 20 (04) : 914 - 931
[4] Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update
Golnaz Yadollahikhales
Julio C. Rojas
Neurotherapeutics, 2023, 20 : 914 - 931
[5] Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease
Liu, Kathy Y.
Villain, Nicolas
Ayton, Scott
Ackley, Sarah F.
Planche, Vincent
Howard, Robert
Thambisetty, Madhav
BRAIN COMMUNICATIONS, 2023, 5 (03)
[6] Anti-amyloid immunotherapy in Alzheimer's Disease
Orgogozo, J. -M.
REVUE NEUROLOGIQUE, 2008, 164 : F95 - F97
[7] Passive Anti-Amyloid Beta Immunotherapies in Alzheimer's Disease: From Mechanisms to Therapeutic Impact
Schreiner, Thomas Gabriel
Croitoru, Cristina Georgiana
Hodorog, Diana Nicoleta
Cuciureanu, Dan Iulian
BIOMEDICINES, 2024, 12 (05)
[8] Will anti-amyloid therapies work for Alzheimer's disease?
St George-Hyslop, Peter H.
Morris, John C.
LANCET, 2008, 372 (9634): : 180 - 182
[9] Patient journey and decision processes for anti-amyloid therapy in Alzheimer’s disease
Brant Mittler
Xavier Cambi
Morgan Biskach
Joel Reisman
Ying Wang
Dan Berlowitz
Peter Morin
Donald R. Miller
Karla Brandao-Viruet
Sophie J. Clare
Kevin Z. Xia
Amir Abbas Tahami Monfared
Michael Irizarry
Quanwu Zhang
Weiming Xia
Journal of Neurology, 2025, 272 (5)
[10] Anti-amyloid antibody treatments for Alzheimer's disease
Perneczky, Robert
Dom, Geert
Chan, Andrew
Falkai, Peter
Bassetti, Claudio
EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (02)

← 1 2 3 4 5 →